Zobrazeno 1 - 7
of 7
pro vyhledávání: '"A61K31/495"'
Autor:
Virginia Tech Intellectual Properties, Inc., Bassaganya-Riera, Josep, Hontecillas, Raquel, Lu, Pinyi
The present invention relates to the field of medical treatments for diseases and disorders. More specifically, the present invention relates to the use of the lanthionine synthetase component C-like (LANCL) proteins as therapeutic targets for novel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2485::d907e61b1bce32d48aa02f569f8553fb
https://hdl.handle.net/10919/72758
https://hdl.handle.net/10919/72758
Pyrrolyl quinoxalindiones of formula (I) and their tautomeric and isomeric forms and their physiologically acceptable salts, in which R is hydrogen, C1-C6 alkyl, substituted by hydroxyl or carboxyl, R is hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=epopatstat__::f835dc12f97ff969d7c7cf6c2273c059
https://register.epo.org/application?number=EP9702913
https://register.epo.org/application?number=EP9702913
Autor:
GLAXO GROUP LTD, WARD SIMON E
Compounds of formula (I) and pharmaceutically acceptable salts thereof are disclosed, wherein: A is optionally substituted phenyl, naphthyl, indolyl, quinolinyl, quinazolinyl, indazolyl, isoquinolinyl or benzofuranyl; X is carbon, Y is CH and === is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=epopatstat__::b0923015628bedf2689eb1c6d59ba85d
https://register.epo.org/application?number=EP0301708
https://register.epo.org/application?number=EP0301708
The present invention concerns novel formulations comprising an antifungal agent having a low solubility in aqueous media, a process for preparing said formulations and pharmaceutical dosage forms comprising said novel formulations for nasal administ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=epopatstat__::daccdf08474ed90410594dcf1f5ba75a
https://register.epo.org/application?number=EP0005679
https://register.epo.org/application?number=EP0005679
Crystalline forms of (S)-2-ethyl-7-fluoro-3-oxo-3,4-dihydro-2H-quinoxaline-1-carboxylic acid isopropyl ester, also known as (S)-1-methylethyl 2-ethyl-7-fluoro-3,4-dihydro-3-oxo-1(2H)-quinoxaline carboxylate, the compound of formula (I), process for t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=epopatstat__::f4c8c3e1dc3dfbc2e46b70f271e1d48a
https://register.epo.org/application?number=EP0000612
https://register.epo.org/application?number=EP0000612
Autor:
MERCK PATENT GMBH, SCHIEMANN KAI, BOETTCHER HENNING, HEINRICH TIMO, HOELZEMANN GUENTER, VAN AMSTERDAM CHRISTOPH, BARTOSZYK GERD, LEIBROCK JOACHIM, SEYFRIED CHRISTOPH
Novel indole derivatives of formula (I), where A , X, R, R and m have the meanings given in claim 1, have a strong affinity for the 5-HT1A and partial affinity for the 5-HT1D receptors. The compounds inhibit serotonin reuptake, display serotonin agon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=epopatstat__::5444c7f6ed8f62c4ff1502e81a75c633
https://register.epo.org/application?number=EP0311132
https://register.epo.org/application?number=EP0311132